Cannara Biotech Inc. announced financial results for the first quarter period ended November 30, 2020. For the period, the company reported gross profit from wholesale transactions was CAD 199,663 or 29.4% compared to nil for the same period of the prior year. Total comprehensive loss of CAD 3.5 million or a loss per share of CAD 0.01 compared to CAD 2.9 million or a loss per share of CAD 0.01 in the same period of the prior year. The company generated lease revenues of CAD 556,932 compared to CAD 527,528 in the same period of the prior year.